Edition:
United Kingdom

Immune Pharmaceuticals Inc (IMNP.OQ)

IMNP.OQ on NASDAQ Stock Exchange Capital Market

0.23USD
9:00pm BST
Change (% chg)

$-0.02 (-6.75%)
Prev Close
$0.25
Open
$0.25
Day's High
$0.25
Day's Low
$0.23
Volume
139,565
Avg. Vol
182,448
52-wk High
$3.43
52-wk Low
$0.22

Chart for

About

Immune Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the development and commercialization of targeted therapeutics in the fields of immuno-inflammation and immuno-oncology. The Company's segment is acquiring, developing and commercializing prescription drug products. Its... (more)

Overall

Beta: 2.17
Market Cap(Mil.): $15.02
Shares Outstanding(Mil.): 10.58
Dividend: --
Yield (%): --

Financials

  IMNP.OQ Industry Sector
P/E (TTM): -- 30.95 32.75
EPS (TTM): -5.60 -- --
ROI: -201.88 14.84 14.38
ROE: -1,487.29 16.34 16.07

BRIEF-Immune Pharmaceuticals Provides Pipeline Update

* IMMUNE PHARMACEUTICALS INC - CONTINUE DISCUSSIONS WITH PARTIES POTENTIALLY INTERESTED IN ACQUIRING CERTAIN OF CYTOVIA'S ASSETS

2:24pm BST

BRIEF-Immune Pharma Presents Positive Results From Phase 2 Trial Of Bullous Pemphigoid Treatment

* IMMUNE PHARMACEUTICALS PRESENTS UPDATED POSITIVE RESULTS FROM PHASE 2 TRIAL OF BERTILIMUMAB IN BULLOUS PEMPHIGOID

15 May 2018

BRIEF-Immune Pharmaceuticals Says Board Will Not Pursue Spin-Off Of Cytovia Unit

* IMMUNE PHARMACEUTICALS PROVIDES UPDATE ON PLANS FOR ONCOLOGY SUBSIDIARY, CYTOVIA, INC.

07 May 2018

Competitors

Earnings vs. Estimates